|
87
|
348
|
7nx4A |
Crystal structure of the tg and egf-like domains of alk |
|
79
|
309
|
7nwzA |
Alk:alkal2 complex |
|
77
|
309
|
7nx3A |
Crystal structure of alk in complex with fab324 |
|
77
|
319
|
7nx1A |
Tg domain of ltk |
|
168
|
603
|
7mn5A |
Structure of the her2/her3/nrg1b heterodimer extracellular domain |
|
165
|
606
|
7mn6B |
Structure of the her2 s310f/her3/nrg1b heterodimer extracellular domain |
|
166
|
606
|
7mn5B |
Structure of the her2/her3/nrg1b heterodimer extracellular domain |
|
173
|
603
|
7mn6A |
Structure of the her2 s310f/her3/nrg1b heterodimer extracellular domain |
|
86
|
297
|
7vkoA |
Crystal structure of trka kinase with repotrectinib |
|
89
|
298
|
7vknA |
Crystal structure of trka (g595r) kinase with repotrectinib |
|
90
|
300
|
7vkmA |
Crystal structure of trka (g595r) kinase domain |
|
84
|
296
|
7olsA |
Mertk kinase domain with type 1.5 inhibitor containing a di-methyl pyrazole group |
|
85
|
296
|
7olxA |
Mertk kinase domain with type 1.5 inhibitor containing a tri-methyl pyrazole group |
|
86
|
296
|
7olvA |
Mertk kinase domain with type 1.5 inhibitor containing a di-methyl, cyano pyrazole group |
|
34
|
184
|
7ofvA |
Nmr-guided design of potent and selective epha4 agonistic ligands |
|
66
|
286
|
7m5zA |
Crystal structure of the mertk kinase domain in complex with inhibitor mips15692 |
|
66
|
234
|
7me4A |
Structure of the extracellular wnt-binding module in drosophila ror2/nrk |
|
79
|
286
|
7lgsA |
Structure of egfr_d770_n771insnpg/v948r in complex with covalent inhibitor osimertinib. |
|
78
|
304
|
7kd6E |
Insulin receptor l1-cr plus alphact fragment in co-complex with fv 83-7 and single-chain insulin sci-b |
|
94
|
308
|
7jxpA |
Egfr kinase (t790m/v948r) in complex with osimertinib and jbj-04-125-02 |
|
86
|
308
|
7k1iA |
Egfr kinase (l858r/v948r) in complex with allosteric inhibitor jbj-09-063 |
|
94
|
308
|
7jxqA |
Egfr kinase (t790m/v948r) in complex with allosteric inhibitor jbj-09-063 |
|
79
|
287
|
7jxhA |
Her2 in complex with jbj-08-178-01 |
|
88
|
308
|
7jxmA |
Egfr kinase (t790m/v948r) in complex with osimertinib and eai045 |
|
86
|
308
|
7jxwA |
Egfr kinase (t790m/v948r) in complex with osimertinib and jbj-09-063 |
|
85
|
313
|
7jxlA |
Egfr kinase (t790m/v948r) in complex with az5104 |
|
88
|
308
|
7jxkA |
Egfr kinase (t790m/v948r) in complex with pf-06747775 and jbj-04-125-02 |
|
89
|
307
|
7k1hA |
Egfr l858r/v948r in complex with osimertinib and allosteric inhibitor jbj-09-063 |
|
88
|
307
|
7jxiA |
Egfr kinase (t790m/v948r) in complex with pf-06747775 |
|
68
|
289
|
7dxlA |
Fragment-based lead discovery of indazole-based compounds as axl kinase inhibitors |
|
83
|
296
|
7eecA |
Crystal structure of epha7 mutant g656r |
|
85
|
296
|
7eedA |
Crystal structure of epha7 mutant d751h |
|
84
|
297
|
7eefA |
Crystal structure of epha7 mutant g656e |
|
90
|
308
|
6xl4A |
Egfr(t790m/v948r) in complex with azd9291 and ddc4002 |
|
72
|
525
|
7mobC |
Cryo-em structure of 2:2 c-met/nk1 complex |
|
94
|
713
|
7mo9E |
Cryo-em map of the c-met ii/hgf i/hgf ii (k4 and sph) sub-complex |
|
114
|
715
|
7mo7B |
Cryo-em structure of 2:2 c-met/hgf holo-complex |
|
96
|
713
|
7moaE |
Cryo-em structure of the c-met ii/hgf i complex bound with hgf ii in a rigid conformation |
|
86
|
322
|
7aeiA |
Studies towards a reversible egfr c797s triple mutant inhibitor series |
|
75
|
289
|
7oamA |
Kinase domain of mertk in complex with compound 8 |
|
92
|
316
|
6wxnA |
Egfr(t790m/v948r) in complex with ln3844 |
|
55
|
193
|
7d85A |
Crystal structure of anti-erbb3 fab isu104 in complex with human erbb3 extracellular domain 3 |
|
93
|
324
|
7aemA |
Studies towards a reversible egfr c797s triple mutant inhibitor series |
|
91
|
316
|
6wa2A |
Crystal structure of egfr(t790m/v948r) in complex with ln3753 |
|
92
|
312
|
6wakA |
A crystal structure of egfr(t790m/v948r) in complex with ln3754 |
|
102
|
309
|
7bttA |
A x-ray cocrystal structure of xmu-mp-5 bound to the alk kinase domain |
|
80
|
278
|
7kpmA |
Crystal structure of hephb1 bound with adp |
|
86
|
295
|
7aw1A |
Mertk kinase domain in complex with a type 2 inhibitor |
|
87
|
295
|
7avzA |
Mertk kinase domain in complex with a bisaminopyrimidine inhibitor |
|
82
|
286
|
7avxA |
Mertk kinase domain in complex with nps-1034 |
